Reply to Comment on “Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuria”
Crossref DOI link: https://doi.org/10.1007/s40273-025-01499-8
Published Online: 2025-05-22
Published Print: 2025-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gallacher, Daniel
Text and Data Mining valid from 2025-05-22
Version of Record valid from 2025-05-22
Article History
Accepted: 6 April 2025
First Online: 22 May 2025
Declarations
:
: No funding was received for the preparation of this letter.
: Daniel Gallacher was a member of the EAG for the appraisal of danicopan.